Liggett, S. B., Kelly, R., Matkovich, S. J., Hahn, H. S., Syed, F. M., Marreez, Y., … Dorn, G. W. (2006). G-Protein Receptor Kinase-5 Polymorphism Influences Therapeutic Efficacy of β-Blockers in Heart Failure. In Journal of Cardiac Failure (Vol. 12, pp. S39–S39). Elsevier BV. https://doi.org/10.1016/j.cardfail.2006.06.138

Liggett, Stephen B., Reagan Kelly, Scot J. Matkovich, Harvey S. Hahn, Faisal M. Syed, Yehia Marreez, Karen L. Case, et al. “G-Protein Receptor Kinase-5 Polymorphism Influences Therapeutic Efficacy of β-Blockers in Heart Failure.” In Journal of Cardiac Failure, 12:S39–S39. Elsevier BV, 2006. https://doi.org/10.1016/j.cardfail.2006.06.138.

Liggett SB, Kelly R, Matkovich SJ, Hahn HS, Syed FM, Marreez Y, et al. G-Protein Receptor Kinase-5 Polymorphism Influences Therapeutic Efficacy of β-Blockers in Heart Failure. In: Journal of Cardiac Failure. Elsevier BV; 2006. p. S39–S39.

Liggett, Stephen B., et al. “G-Protein Receptor Kinase-5 Polymorphism Influences Therapeutic Efficacy of β-Blockers in Heart Failure.” Journal of Cardiac Failure, vol. 12, no. 6, Elsevier BV, 2006, pp. S39–S39. Crossref, doi:10.1016/j.cardfail.2006.06.138.

Liggett SB, Kelly R, Matkovich SJ, Hahn HS, Syed FM, Marreez Y, Case KL, McGuire N, Brunskill EW, Odley AM, Parekh R, Sparks L, Koch WJ, Freeman GL, Kardia SLR, Dorn GW. G-Protein Receptor Kinase-5 Polymorphism Influences Therapeutic Efficacy of β-Blockers in Heart Failure. Journal of Cardiac Failure. Elsevier BV; 2006. p. S39–S39.